Prothena Corp PLC (PRTA)
20.56
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
20.57
+0.01
(+0.05%)
After-Hours: 20:00
Prothena Enterprise Value: 485.66M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 485.66M |
April 24, 2024 | 485.66M |
April 23, 2024 | 485.66M |
April 22, 2024 | 524.88M |
April 19, 2024 | 517.90M |
April 18, 2024 | 486.20M |
April 17, 2024 | 509.30M |
April 16, 2024 | 527.57M |
April 15, 2024 | 562.48M |
April 12, 2024 | 575.91M |
April 11, 2024 | 631.78M |
April 10, 2024 | 607.07M |
April 09, 2024 | 645.75M |
April 08, 2024 | 653.27M |
April 05, 2024 | 636.62M |
April 04, 2024 | 630.71M |
April 03, 2024 | 684.43M |
April 02, 2024 | 667.78M |
April 01, 2024 | 785.96M |
March 28, 2024 | 711.83M |
March 27, 2024 | 732.78M |
March 26, 2024 | 710.75M |
March 25, 2024 | 745.67M |
March 22, 2024 | 773.61M |
March 21, 2024 | 755.88M |
Date | Value |
---|---|
March 20, 2024 | 751.58M |
March 19, 2024 | 729.02M |
March 18, 2024 | 729.02M |
March 15, 2024 | 781.66M |
March 14, 2024 | 803.69M |
March 13, 2024 | 917.58M |
March 12, 2024 | 860.63M |
March 11, 2024 | 888.57M |
March 08, 2024 | 1.005B |
March 07, 2024 | 955.18M |
March 06, 2024 | 957.33M |
March 05, 2024 | 904.15M |
March 04, 2024 | 902.53M |
March 01, 2024 | 913.82M |
February 29, 2024 | 863.32M |
February 28, 2024 | 937.99M |
February 27, 2024 | 1.009B |
February 26, 2024 | 895.01M |
February 23, 2024 | 843.44M |
February 22, 2024 | 828.94M |
February 21, 2024 | 834.31M |
February 20, 2024 | 860.10M |
February 16, 2024 | 886.42M |
February 15, 2024 | 913.28M |
February 14, 2024 | 846.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-123.26M
Minimum
Aug 23 2019
3.460B
Maximum
May 05 2023
1.072B
Average
869.33M
Median
Sep 14 2022
Enterprise Value Benchmarks
Amarin Corp PLC | 24.55M |
Jazz Pharmaceuticals PLC | 10.78B |
Iterum Therapeutics PLC | 20.82M |
GH Research PLC | 384.74M |
Mural Oncology PLC | -211.12M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -67.48M |
Revenue (Quarterly) | 0.316M |
Total Expenses (Quarterly) | 78.83M |
EPS Diluted (Quarterly) | -1.26 |
Profit Margin (Quarterly) | -21.35K% |
Earnings Yield | -13.62% |
Normalized Earnings Yield | -13.62 |